Search Results
Adcock puts off vote on CFR buyout again; J&J petitions FDA on biosim names; GW wins French OK for Sativex;
Vaccines News > Astellas inks deal to create a portfolio of vaccine-focused biotechs. Story > H1N1 deaths drive a surge in demand for flu vaccine. Report > China gives hep B vaccine a clean bill of health but suspicions remain. News > Study finds giving Prevnar and flu vaccine together raises risk ...
GW Pharma raises $88M for orphan disease drug; Flexion pitches $86M IPO; Adimab lines up antibody deals with 3 biotechs;
implications. Report Vaccines News > Astellas inks deal to create a portfolio of vaccine-focused biotechs. Story > H1N1 deaths drive a surge in demand for flu vaccine. Report > China gives hep B vaccine ...
KineMed plots $51M IPO; Globus snaps up robotic surgery company;
implications. Report Vaccines News > Astellas inks deal to create a portfolio of vaccine-focused biotechs. Story > H1N1 deaths drive a surge in demand for flu vaccine. Report > China gives hep B vaccine ...
Lombard plots a U.S. IPO as aortic aneurysm device takes off
Lombard Medical is planning a U.S. IPO to support the commercialization of its Aorfix stent.--Courtesy of Lombard Medical London's Lombard Medical is riding high on a spike in demand for its aortic repair device, and now the company has its heart set on a stateside IPO, planning to file ...
Billionaire backs new program for a pioneering Alzheimer's vaccine from AC Immune
bags $46M to wrap cancer vaccine PhIII Defining 'fierce' in the modern age of drug and device ...
Rumored Novartis, Merck asset swap has interesting manufacturing implications
would pick up Novartis modern vaccines plant in Holly Springs, NC, to compliment its own extensive vaccine manufacturing in North Carolina, while Novartis would get help for a business that has been ...
Wanna trade? Novartis and Merck are reportedly negotiating a $5B unit swap
in the field. Merck's vaccines business, already strong, could add products such as Novartis' ...
UPDATED: Intercept shares dazzle after early success of PhIIb liver disease drug trial
Related Articles: Intercept Pharma, Kythera Bio jump out of the IPO gate Intercept Pharma files for $75M ...
Patheon's deal for DSM would transform it into the second largest CMO in the world
acquisitions over the years."- here's is the preliminary proxy filing- get the amended going private ...
GE buys Thermo's vaccine production assets; Zydus Cadila plans pentavalent vaccine launch;
> GE has bought vaccine production assets from Thermo Fisher Scientific ($TMO). Piece > Zydus Cadila plans to introduce a pentavalent vaccine in India by 2015. News > The University of Texas is trying to attract GlaxoSmithKline ($GSK) to its vaccine technology. Article > Microbix ...
